e-learning
resources
London 2016
Tuesday, 06.09.2016
Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents
Marta Ollé (Barcelona, Spain), Marta Ollé, Xavier Muñoz, Jokin Yllera, Mª Dolores Untoria, Daniel Álvarez, Mª Jesús Cruz
Source:
International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Session:
Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Session type:
Thematic Poster
Number:
4270
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marta Ollé (Barcelona, Spain), Marta Ollé, Xavier Muñoz, Jokin Yllera, Mª Dolores Untoria, Daniel Álvarez, Mª Jesús Cruz. Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents. Eur Respir J 2016; 48: Suppl. 60, 4270
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
Targeting IL33-ST2 pathway in virus-induced exacerbation of experimental asthma
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
The effect of different PV extracts in the treatment of asthma in an animal model
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
RIG-I receptors induced by dsRNA challenges in an HDM-mouse model of asthma exacerbation
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014
Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for the pathogenesis of allergic airways disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Investigating antioxidant therapy for steroid-resistant asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Developing a chronic murine model that better reflects the clinical features of the human asthma
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Adjuvant-free mouse model of allergic asthma
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
The effects of clinically relevant reference agents in a mouse model of severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
A murine ovalbumin model exhibits molecular features of steroid insensitive human asthma
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Effects of prenatal tobacco smoke exposure on pulmonary signaling networks in a murine model
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Immunomodulatory role of IL-37 in asthma pathogenesis
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Exosomal microRNAs in the serum are potential real-time biomarkers for allergic inflammation in the airway of mice
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept